COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,672 Articles (22,913 medRxiv, 8,759 bioRxiv)

Most recent first Previous |  Page 248: Articles 2471-2480  | Next

Medical Costs, Health Care Utilization, and Productivity Losses Associated With Hypertension by COVID-19 Among US Commercial Enrollees
Lee, J. S., Zhang, Y., Wang, Y., Park, J., Kumar, A., Donald, B., Luo, F., Roy, K.
10.1101/2024.05.31.24308307 — Posted: 2024-06-01
Impact of rotavirus vaccination in Malawi from 2012 to 2022 compared to model predictions before, during, and after the COVID-19 pandemic
Pitzer, V. E., Ndeketa, L., Asare, E. O., Hungerford, D., Jere, K. C., Cunliffe, N. A.
10.1101/2024.05.29.24308124 — Posted: 2024-05-31
Characterizing a Lethal CAG-ACE2 Transgenic Mouse Model for SARS-CoV-2 infection with Using Cas9-Enhanced Nanopore Sequencing
Smirnov, A., Nurislamov, A., Koncevaya, G., Serova, I., Kabirova, E., Chuyko, E., Maltceva, E., Savoskin, M., Zadorozhny, D., Svyatchenko, V. A., Protopopova, E. V., Taranov, O. S., Legostaev, S. S., Loktev, V. B., Serov, O., Battulin, N.
10.1101/2024.05.30.596396 — Posted: 2024-05-31
Transfer of IgG from Long COVID patients induces symptomology in mice
Chen, H.-J., Appelman, B., Willemen, H., Bos, A., Prado, J., Geyer, C. E., Silva Santos Ribeiro, P., Versteeg, S., Larsen, M. D., Schuchner, E., Bomers, M. M. K., Lavell, A. H. A., Amsterdam UMC COVID-19 biobank, , Charlton, B., Wust, R., Wiersinga, W. J., van Vugt, M., Vidarsson, G., Eijkelkamp, N., den Dunnen, J.
10.1101/2024.05.30.596590 — Posted: 2024-05-31
Disruption of Immune Responses By Type I Diabetes Exacerbates SARS-CoV-2 Mediated Lung Injury
Kass Gergi, S., Zhao, G., Wong, J., Weiner, A. I., Adam Tzivelekidis, S., Gentile, M. E., Mendoza, M., Holcomb, N. P., Li, X., Singh, M., Vaughan, A. E.
10.1101/2024.05.31.596857 — Posted: 2024-05-31
Variable rates of SARS-CoV-2 evolution in chronic infections
Smith, E., Hamilton, W. L., Warne, B., Walker, E. R., Jahun, A. S., Hosmillo, M., ISARIC Consortium, , Gupta, R. K., Goodfellow, I., Gkrania-Klotsas, E., Torok, M. E., Illingworth, C. J. R.
10.1101/2024.05.31.596818 — Posted: 2024-05-31
Conceptual framework of episodic disability in the context of Long COVID: Findings from a community-engaged international qualitative study
O'Brien, K. K., Brown, D. A., McDuff, K., St. Clair-Sullivan, N., Chan Carusone, S., Thomson, C., McCorkell, L., Wei, H., Goulding, S., O'Hara, M., Roche, N., Stokes, R., Kelly, M., Cheung, A. M., Erlandson, K. M., Harding, R., Vera, J. H., Bergin, C., Avery, L., Robinson, L., Bannan, C., Torres, B., O'Donovan, I., Malli, N., Solomon, P.
10.1101/2024.05.28.24308048 — Posted: 2024-05-30
The Impact of Preprints on COVID-19 Research Dissemination: A Quantitative Analysis of Journal Publications
Tsunoda, H., Sun, Y., Nishizawa, M., Liu, X., Amano, K., Kominami, R.
10.1101/2024.05.28.596359 — Posted: 2024-05-29
SARS-CoV-2 correlates of protection from infection against variants of concern
Sun, K., Bhiman, J. N., Tempia, S., Kleynhans, J., Madzorera, V. S., Mkhize, Q., Kaldine, H., McMorrow, M. L., Wolter, N., Moyes, J., Carrim, M., Martinson, N. A., Kahn, K., Lebina, L., du Toit, J. D., Mkhencele, T., von Gottberg, A., Viboud, C., Moore, P. L., Cohen, C., PHIRST-C group
10.1101/2024.05.28.24308095 — Posted: 2024-05-29
Continuous quality improvement with a two-step strategy effective for large-scale SARS-CoV-2 screening at the Tokyo 2020 Olympic and Paralympic Games
Miyachi, H., Asai, S., Kuroki, R., Omi, K., Ikenoue, C., Shimada, S.
10.1101/2024.05.29.24307666 — Posted: 2024-05-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).